CVRx, Inc.
CVRx, Inc.（CVRX）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · CVRX · 截至 2026年6月9日
活动摘要
买入笔数
9
P-Purchase only
卖出笔数
12
近12个月
买卖比
0.75
Buy/Sell (by trades)
整体情绪
CVRx, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
CVRX 季度内部人买卖趋势
CVRX 内幕交易卖出 · CVRX 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · CVRX CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
CVRX 高管卖出股份 · CVRX 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Jun 1, 2026 | Nielsen Kirk G. Director | Award | 8,720 | — | Form 4 |
| Jun 1, 2026 | Jain Mudit K. Director | Award | 8,720 | — | Form 4 |
| Jun 1, 2026 | SLATTERY JOSEPH P Director | Award | 8,720 | — | Form 4 |
| Jun 1, 2026 | Hill, Mitch C. Director | Award | 8,720 | — | Form 4 |
| Jun 1, 2026 | Ballinger Kevin J. Director | Award | 8,720 | — | Form 4 |
| Jun 1, 2026 | SHADAN MARTHA Director | Award | 8,720 | — | Form 4 |
| Jun 1, 2026 | DALE MICHAEL D Director | Award | 29,005 | — | Form 4 |
| Feb 27, 2026 | Adamson Philip B. Chief Medical Officer | Award | 41,000 | — | Form 4 |
| Mar 2, 2026 | Adamson Philip B. Chief Medical Officer | Sale | 1,262 | $10K | Form 4 |
| Mar 2, 2026 | Morrison Gregory CHIEF HUMAN RESOURCES OFFICER | Award | 34,000 | — | Form 4 |
| Feb 27, 2026 | Hykes Kevin PRES & CEO · Director | Award | 159,000 | — | Form 4 |
| Mar 2, 2026 | Hykes Kevin PRES & CEO · Director | Sale | 7,763 | $61K | Form 4 |
| Feb 27, 2026 | VERRASTRO PAUL CHIEF MKTG & STRAT OFFICER | Award | 45,000 | — | Form 4 |
| Mar 2, 2026 | VERRASTRO PAUL CHIEF MKTG & STRAT OFFICER | Sale | 1,284 | $10K | Form 4 |
| Feb 27, 2026 | OASHEIM JARED CHIEF FINANCIAL OFFICER | Award | 61,000 | — | Form 4 |
| Mar 2, 2026 | OASHEIM JARED CHIEF FINANCIAL OFFICER | Sale | 1,744 | $14K | Form 4 |
| Feb 27, 2026 | John Robert Allen Chief Revenue Officer | Award | 35,000 | — | Form 4 |
| Mar 2, 2026 | John Robert Allen Chief Revenue Officer | Sale | 3,964 | $31K | Form 4 |
| Feb 27, 2026 | Binkowski Brent CHIEF OPERATING OFFICER | Award | 15,000 | — | Form 4 |
| Feb 20, 2026 | Jain Mudit K. Director | Purchase | 46,800 | $298K | Form 4 |
| Feb 18, 2026 | Jain Mudit K. Director | Purchase | 600 | $3K | Form 4 |
| Nov 26, 2025 | JOHNSON & JOHNSON 10 percent owner | Sale | 6,337 | $64K | Form 4 |
| Nov 21, 2025 | JOHNSON & JOHNSON 10 percent owner | Sale | 500 | $5K | Form 4 |
| Nov 24, 2025 | JOHNSON & JOHNSON 10 percent owner | Sale | 2,200 | $22K | Form 4 |
| Nov 12, 2025 | JOHNSON & JOHNSON 10 percent owner | Sale | 1,000 | $10K | Form 4 |
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 CVRX 内幕交易
CVRX 内幕交易
CVRx, Inc.（CVRX）内幕交易数据来源于公司内部人（包括JOHNSON & JOHNSON (10 percent owner), Jain Mudit K. (Director), Adamson Philip B. (Chief Medical Officer)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。CVRX内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看CVRx, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
CVRX 内幕交易 · 5个问题CVRx, Inc.（CVRX）的内部人包括高管和董事，如JOHNSON & JOHNSON (10 percent owner), Jain Mudit K. (Director), Adamson Philip B. (Chief Medical Officer)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026